Chemical Name: (1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (as per EP)
Synonym: anti-cefpodoxime proxetil
Smiles: O=C(C(N12)=C(COC)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N/OC)=O)C1=O)OC(OC(OC(C)C)=O)C
Inchi: InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h7-10,14-15,18H,6H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,15?,18-/m1/s1
Stability indicating HPLC method development and validation for the simultaneous determination of Cefpodoxime Proxetil and Ofloxacin in its dosage forms
By Ghode, Prashant D.; Pawar, Sunil P.
From International Journal of Pharma and Bio Sciences (2015), 6(2), 183-193
Stability indicating method development degradation studies and validation of cefpodoxime proxetil by RP-HPLC method
By Kamalesh, G.; Madhuri, D.; Nagarajan, G.
From International Journal for Pharmaceutical Research Scholars (2014), 3(4), 269-275, 7 pp..
Characterization of impurities in cefpodoxime proxetil using LC-MS (n)
By Li Jin; Zhang Dousheng; Hu Changqin
From Acta pharmaceutica Sinica. B (2014), 4(4), 322-32